Human VTCN1/B7-H4/B7h.5 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_024626.4)
Cat. No.: pGMPC000218
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human VTCN1/B7-H4/B7h.5 Non-Viral expression plasmid (overexpression vector) for mouse VTCN1 overexpression in unique cell transient transfection and stable cell line development.
Go to
B7‑H4/B7-H4/VTCN1/VTCN1/B7-H4 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMPC000218 |
Gene Name | VTCN1 |
Accession Number | NM_024626.4 |
Gene ID | 79679 |
Species | Human |
Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
Insert Length | 849 bp |
Gene Alias | B7-H4,B7h.5,B7H4,B7S1,B7X,PRO1291,VCTN1 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | EF1 |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCTTCCCTGGGGCAGATCCTCTTCTGGAGCATAATTAGCATCATCATTATTCTGGCTGGAGCAATTGCACTCATCATTGGCTTTGGTATTTCAGGGAGACACTCCATCACAGTCACTACTGTCGCCTCAGCTGGGAACATTGGGGAGGATGGAATCCTGAGCTGCACTTTTGAACCTGACATCAAACTTTCTGATATCGTGATACAATGGCTGAAGGAAGGTGTTTTAGGCTTGGTCCATGAGTTCAAAGAAGGCAAAGATGAGCTGTCGGAGCAGGATGAAATGTTCAGAGGCCGGACAGCAGTGTTTGCTGATCAAGTGATAGTTGGCAATGCCTCTTTGCGGCTGAAAAACGTGCAACTCACAGATGCTGGCACCTACAAATGTTATATCATCACTTCTAAAGGCAAGGGGAATGCTAACCTTGAGTATAAAACTGGAGCCTTCAGCATGCCGGAAGTGAATGTGGACTATAATGCCAGCTCAGAGACCTTGCGGTGTGAGGCTCCCCGATGGTTCCCCCAGCCCACAGTGGTCTGGGCATCCCAAGTTGACCAGGGAGCCAACTTCTCGGAAGTCTCCAATACCAGCTTTGAGCTGAACTCTGAGAATGTGACCATGAAGGTTGTGTCTGTGCTCTACAATGTTACGATCAACAACACATACTCCTGTATGATTGAAAATGACATTGCCAAAGCAACAGGGGATATCAAAGTGACAGAATCGGAGATCAAAAGGCGGAGTCACCTACAGCTGCTAAACTCAAAGGCTTCTCTGTGTGTCTCTTCTTTCTTTGCCATCAGCTGGGCACTTCTGCCTCTCAGCCCTTACCTGATGCTAAAATAA |
ORF Protein Sequence | MASLGQILFWSIISIIIILAGAIALIIGFGISGRHSITVTTVASAGNIGEDGILSCTFEPDIKLSDIVIQWLKEGVLGLVHEFKEGKDELSEQDEMFRGRTAVFADQVIVGNASLRLKNVQLTDAGTYKCYIITSKGKGNANLEYKTGAFSMPEVNVDYNASSETLRCEAPRWFPQPTVVWASQVDQGANFSEVSNTSFELNSENVTMKVVSVLYNVTINNTYSCMIENDIAKATGDIKVTESEIKRRSHLQLLNSKASLCVSSFFAISWALLPLSPYLMLK |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Biosimilar | GMP-Bios-ab-019 | Pre-Made Alsevalimab biosimilar, Whole mAb, Anti-VTCN1 Antibody: Anti-B7-H4/B7H4/B7S1/B7X/B7h.5/PRO1291/VCTN1 therapeutic antibody |
Target Antibody | GM-Tg-g-IP0154-Ab | Anti-VTCN1 monoclonal antibody |
Target Antigen | GM-Tg-g-IP0154-Ag | VTCN1 protein |
ORF Viral Vector | pGMLP004468 | Human VTCN1 Lentivirus plasmid |
ORF Viral Vector | pGMPC000218 | Human VTCN1 Mammalian (Non-Viral Vector) plasmid |
ORF Viral Vector | vGMLP004468 | Human VTCN1 Lentivirus particle |
Target information
Target ID | GM-IP0154 |
Target Name | B7‑H4/B7-H4/VTCN1 |
Gene Group Identifier (Target Gene ID in Homo species) |
79679 |
Gene ID |
100066328 (Equus caballus), 101086586 (Felis catus), 242122 (Mus musculus), 295322 (Rattus norvegicus) 483140 (Canis lupus familiaris), 539919 (Bos taurus), 714123 (Macaca mulatta), 79679 (Homo sapiens) |
Gene Symbols & Synonyms | VTCN1,Vtcn1,B7x,B7h4,B7s1,RGD1311204,B7X,B7H4,B7S1,B7-H4,B7h.5,VCTN1,PRO1291 |
Target Alternative Names | B7‑H4, B7-H4, VTCN1,V-set domain-containing T-cell activation inhibitor 1,B7 homolog 4 (B7-H4), B7h.5, Immune costimulatory protein B7-H4, Protein B7S1, T-cell costimulatory molecule B7x,B7X,B7H4,B7S1,B7-H4,B7h.5,VCTN1,PRO1291 |
Uniprot Accession |
Q501W4,Q7TSP5,Q7Z7D3
Additional SwissProt Accessions: Q7TSP5,Q501W4,Q7Z7D3 |
Uniprot Entry Name | |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target, Immuno-oncology Target, INN Index |
Disease | Ovary Cancer |
Disease from KEGG | Cell adhesion molecules |
Gene Ensembl | ENSECAG00000008749, ENSMUSG00000051076, ENSCAFG00845029358, ENSBTAG00000062774, ENSMMUG00000016964, ENSG00000134258 |
Target Classification | Checkpoint-Immuno Oncology |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.